Skip to content
August 15, 2022

Equity.Guru

Investment information for the new generation

colchicine

Lexaria Bioscience (LEXX.Q) announced today that its tolerability and pharmacokinetic study VIRAL-A20-3 has been completed with positive results.     The VIRAL-A20-3 study was performed using Sprague-Dawley rats, with…